Tag Archives: EU

How Good for UK Pharma is the European Union?

As the United Kingdom debate about whether to stay in the European Union becomes more bitter and intense, an insight into how EU membership impacts on medicines and pharmaceuticals has appeared from a British politician who was until recently the UK Government Adviser on Life Sciences, George Freeman. His view—which is less than rosy—is worth […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , | 1 Comment

The EMA Turns 20: What Does It Want to Be?

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014. The European Medicines Agency (EMA) is 20 years old this year — and it confronts many of the problems familiar to anyone at that age. After the vigorous growth and boundless optimism of its […]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment

Europe's IMI Looks to Portugal and Finland to Lead Scientific Committee

Europe’s Innovation Medicines Initiative (IMI) has appointed experts from Portugal and Finland to chair the IMI Scientific Committee. Professor Maria Beatriz da Silva Lima of the University of Lisbon in Portugal will be the new Chair; Professor Markus Perola of Finland’s National Institute for Health and Welfare was appointed Vice Chair. The IMI is the […]
Posted in Europe, Global | Also tagged , , , | Leave a comment

Europe: Early Communications with Regulators is Essential for SMEs

With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process. Europe’s regulatory agencies have been stepping up their support for small- and medium-sized enterprises (SMEs), including micro companies, in an effort to stimulate more development of innovative […]
Posted in Europe, Global, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment

No Rapid European Turn-Around at the Turn of the Year

By Peter O’ Donnell. It is not only the specific issue of clinical trials rules that hangs in the balance as Europe shifts from 2013 to 2014. Many of the outstanding questions about the European Union’s attempt to update its rules will not be answered until the European Parliament finds time in the new year to […]
Posted in Europe, Guest Blog, healthcare, Regulatory | Also tagged , , , | Leave a comment
  • Categories

  • Meta